PORTFOLIO NEWS: TechCrunch: Duffl’s David Lin dishes on why traditional rapid grocery delivery is not working  Read More

BROADCAST: Consumers are ‘Frontloading’ Holiday Spending: Larry Cheng on Fox Business  Read More

TEAM NEWS: Tomy Han Ranked #24 on the Insider 71 rising-star VCs who shook up the industry in 2022  Read More

ANALYSIS: Rule of 40 Index, now live with time series data: Explore

VOLITION VIEWPOINTS: Five Ways to Build a Sustainable Execution Strategy (Hint: Be A Thermostat, Not A Thermometer)  Read More

TEAM NEWS: Volition Capital Vice President Claude de Jocas Named a 2022 Top Women Leader in Growth Investing  Read More

Volition Capital Announces Closing of Fund V with $675M in Capital Commitments: Volition Capital Announces Closing of Volition Capital Fund V, L.P. with $675M in Capital Commitments  Read More

< 1

Medly co-founder Chirag Kulkarni in India West: Four Indian Americans Among Forbes ‘30 Under 30’ List for Marketing and Advertising

Article originally published in India West 

More than a handful of Indian American and South Asian Americans were named among a 30-plus person group in the 10th annual Forbes “30 Under 30” in the Marketing & Advertising category.

Among those rewriting the rules of brand engagement are Indian Americans Chirag Kulkarni, Apoorva Dornadula, Pratham Mittal, Anish Dalal, and Pakistani Americans Faizan Bhatty and Asad J. Malik.

Kulkarni, 25, is the co-founder of Medly Pharmacy.

Tired of long wait times at the pharmacy, Kulkarni set out in 2017 to build a better drugstore along with a pair of second-generation pharmacy owners, the profile says.

“We realized how broken it was for millions of consumers, not just myself,” says Kulkarni, now cofounder and CMO of Medly, which has raised $110 million for the online pharmacy, it said.

In addition to same-day prescription delivery, Medly’s app connects customers with staff pharmacists who answer questions in a dozen languages. And while competitors like Capsule invest in hip branding to attract users, Kulkarni elected to pour marketing bucks into persuading doctors to refer patients to Medly, Forbes adds about Kulkarni.

It’s paid off: In July, Medly served 70,000 patients with more than 500,000 prescriptions, and the company is on track for $200 million in revenue this year, the outlet said.

Read the full article here.

ALL ARTICLES
BACK TO TOP